MorphoSys AG Completes Sale of AbD Serotec to Bio-Rad Laboratories, Inc.
MorphoSys AG announced that the sale of its research and diagnostic antibody segment AbD Serotec to Bio-Rad Laboratories, Inc. has been completed. All assets and liabilities of the AbD Serotec segment of MorphoSys AG as well as all shares of the subsidiaries MorphoSys UK Ltd., MorphoSys AbD GmbH and MorphoSys United States, Inc. have been transferred to Bio-Rad.
- Share this
- Digg this